Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis to cut 680 jobs in product development
Reuters
Tue, 04/9/24 - 11:09 am
Tags:
Novartis, layoffs, drug development
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
BioSpace
Fri, 04/5/24 - 11:37 am
Tags:
Novartis, Pluvicto, prostate cancer, clinical trials, radioligands
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
Tags:
biotech, M&A, IPOs, CG Oncology, Kyverna Therapeutics, Contineum Therapeutics, Boundless Bio, CymaBay Therapeutics, Gilead Sciences, MorphoSys, Novartis, Fusion Pharmaceuticals, AstraZeneca, Ambryx, JNJ, Inhibrix, Aventis
Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
Tags:
China, Pharma CEOs, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Novartis, Pfizer, Takeda
Ex-Novartis exec sets out to create ‘Apple of AI’
Pharma Voice
Mon, 03/18/24 - 05:12 pm
Tags:
artificial intelligence, Aily Labs, Novartis, generative AI, Bianca Anghelina
US appeals court revives Regeneron's antitrust lawsuit against Novartis
Yahoo/Reuters
Mon, 03/18/24 - 05:09 pm
Tags:
Novartis, Regeneron, legal, Eylea, Lucentis, antitrust
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
Tags:
M&A, Bristol Myers Squibb, Novartis, AstraZeneca, Novo Nordisk, Pfizer
Novartis lays out $256M for antibody plant expansion in Singapore, plots 100 hires
Fierce Pharma
Sun, 03/17/24 - 09:27 pm
Tags:
Novartis, Singapore, drug manufacturing
Novartis hits the cGAS, taking option to buy IFM unit for $90M upfront
Fierce Biotech
Wed, 03/13/24 - 10:40 am
Tags:
Novartis, cGAS, IFM Therapeutics
Novartis' BTK inhibitor beats placebo in dermatology trial, lining up another potential indication
Fierce Biotech
Sun, 03/10/24 - 08:29 pm
Tags:
Novartis, dermatology, Btk inhibitors, remibrutinib, hidradenitis suppurativa, clinical trials
Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage
Forbes
Wed, 03/6/24 - 11:25 am
Tags:
Roche, Novartis, Xolair, insurers, food allergies
Novartis reports data from Phase IIIb trial of SMA therapy
Clinical Trials Arena
Tue, 03/5/24 - 11:15 am
Tags:
Novartis, SMA, clinical trials, Zolgensma
Why is pharma going gaga for radiopharmaceuticals?
Pharmaphorum
Tue, 02/27/24 - 11:19 am
Tags:
radiopharmaceuticals, oncology, Novartis, Eli Lilly, Bristol Myers Squibb
Roche's Xolair reduces reactions to severe food allergies in study
Reuters
Sun, 02/25/24 - 05:36 pm
Tags:
Roche, Novartis, Xolair, clinical trials, food allergies
What did Big Pharma CEOs get paid in 2023?
Medical Marketing and Media
Fri, 02/23/24 - 10:22 am
Tags:
Pharma CEOs, executive pay, AstraZeneca, Roche, Novartis
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Tags:
Novo Nordisk, Novartis, JNJ, Bristol Myers Squibb, legal, Inflation Reduction Act, drug pricing
Novartis, zeroing in on innovative meds, launches strategic review of India outfit
Fierce Pharma
Sun, 02/18/24 - 08:36 pm
Tags:
Novartis, India
FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies
Fierce Pharma
Sun, 02/18/24 - 08:31 pm
Tags:
Roche, Novartis, Xolair, food allergies, FDA
Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year
Fierce Pharma
Mon, 02/5/24 - 11:16 pm
Tags:
Novartis, Roche, Pharma CEOs, executive pay, Vas Narasimhan, Thomas Schinecker
Novartis in the lead to acquire cancer drug developer MorphoSys-sources
NASDAQ.com/Reuters
Mon, 02/5/24 - 11:28 am
Tags:
Novartis, M&A, MorphoSys, cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.